Nephrogen Biotech
June 17, 2025
Start-Up Stadium
Metabolic Diseases
North Lobby
Nephrogen is a preclinical biotech spin-out from Stanford University developing curative gene therapies for kidney and pancreatic diseases.
Company HQ City:
New York
Company HQ State:
NY
Company HQ Country:
USA
Year Founded:
2022
CEO
Demetri Maxim
Website
Nephrogenbiotech.com
Speakers
.jpg)
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}